Leading African pharmaceutical Cooper Pharma broke ground for their $USD 6 million pharmaceutical plant in Rwanda, The factory whose completion is set for 2019, will produce beta-lactam antibiotics and non-beta lactam antibiotics according to the market’s demand. To better understand how this will help Rwanda reduce the import bill on drugs, CNBC Africa’s Michael Mugisha filed this report.